Patents Assigned to Invitae Corporation
  • Patent number: 11149308
    Abstract: The invention relates to assembly of sequence reads. The invention provides a method for identifying a mutation in a nucleic acid involving sequencing nucleic acid to generate a plurality of sequence reads. Reads are assembled to form a contig, which is aligned to a reference. Individual reads are aligned to the contig. Mutations are identified based on the alignments to the reference and to the contig.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: October 19, 2021
    Assignee: Invitae Corporation
    Inventors: Gregory Porreca, Caleb Kennedy
  • Publication number: 20210269874
    Abstract: The invention relates to assembly of sequence reads. The invention provides a method for identifying a mutation in a nucleic acid involving sequencing nucleic acid to generate a plurality of sequence reads. Reads are assembled to form a contig, which is aligned to a reference. Individual reads are aligned to the contig. Mutations are identified based on the alignments to the reference and to the contig.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 2, 2021
    Applicant: Invitae Corporation
    Inventors: Gregory PORRECA, Caleb KENNEDY
  • Publication number: 20210269875
    Abstract: The invention relates to assembly of sequence reads. The invention provides a method for identifying a mutation in a nucleic acid involving sequencing nucleic acid to generate a plurality of sequence reads. Reads are assembled to form a contig, which is aligned to a reference. Individual reads are aligned to the contig. Mutations are identified based on the alignments to the reference and to the contig.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 2, 2021
    Applicant: Invitae Corporation
    Inventors: Gregory PORRECA, Caleb KENNEDY
  • Patent number: 10995370
    Abstract: Provided herein are novel methods, systems and processes for generating and analyzing sequence data for the determination of the presence or absence of one or more genetic variations within a genome of a subject.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: May 4, 2021
    Assignee: INVITAE CORPORATION
    Inventors: Erik Gafni, Swaroop Aradhya, Leah Matzat, Eric Olivares, Vinayak Kulkarni, Joshua Paul
  • Patent number: 10648103
    Abstract: Provided herein, in some embodiments, are novel compositions and improved methods for nucleic acid manipulation and analysis that can be applied to multiplex nucleic acid sequencing. In certain embodiments, the novel compositions and methods presented herein are more cost effective, more conducive to automation, and faster than traditional approaches. Also provided herein are novel blocking nucleic acids.
    Type: Grant
    Filed: October 8, 2015
    Date of Patent: May 12, 2020
    Assignee: INVITAE CORPORATION
    Inventor: Eric Olivares
  • Patent number: 10395760
    Abstract: Provided herein are novel methods, systems and processes for mapping sequence reads to a modified reference genome and determining the presence or absence of a genetic variation, or the likelihood thereof, in a gene of interest in a subject.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: August 27, 2019
    Assignee: INVITAE CORPORATION
    Inventors: Daniel J. Kvitek, Erik Gafni
  • Patent number: 9624533
    Abstract: Methods for multiplex ligation-dependent probe amplification include (a) providing a sample tissue to query different target nucleic acids, (b) providing different probe sets for each of the target nucleic acids, each probe set including a first locus specific probe having a first adapter sequence and a first target specific portion and a second locus specific probe having a second adapter sequence, and a second target specific portion adjacent to the first target specific portion, (c) hybridizing the probe sets to the target sequences to form hybridization complexes, (d) ligating the hybridization complexes to form ligated probes, (e) amplifying the ligated probes to form amplicons, the amplifying step being carried out with a first universal primer including a region complementary to the first adapter sequence and a second universal primer including a region complementary to the second adapter sequence, and (f) detecting the amplicons in a detection system by sequencing each of the amplicons.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: April 18, 2017
    Assignee: INVITAE CORPORATION
    Inventors: Eric Olivares, Jon Sorenson, Tom Landers
  • Publication number: 20140235470
    Abstract: Methods for multiplex ligation-dependent probe amplification include (a) providing a sample tissue to query different target nucleic acids, (b) providing different probe sets for each of the target nucleic acids, each probe set including a first locus specific probe having a first adapter sequence and a first target specific portion and a second locus specific probe having a second adapter sequence, and a second target specific portion adjacent to the first target specific portion, (c) hybridizing the probe sets to the target sequences to form hybridization complexes, (d) ligating the hybridization complexes to form ligated probes, (e) amplifying the ligated probes to form amplicons, the amplifying step being carried out with a first universal primer including a region complementary to the first adapter sequence and a second universal primer including a region complementary to the second adapter sequence, and (f) detecting the amplicons in a detection system by sequencing each of the amplicons.
    Type: Application
    Filed: December 6, 2013
    Publication date: August 21, 2014
    Applicant: INVITAE CORPORATION
    Inventors: Eric Olivares, Jon Sorenson, Tom Landers
  • Publication number: 20140162257
    Abstract: Systems and methods for biological sample processing are described. A production line extracts genomic DNA from a biological sample, amplifies target components of the sample and produces sequence data for markers from the amplified components. The markers are associated with tests identified in a requisition received with the sample and some markers may be associated with unrequisitioned tests. A sample information management system (SIMS) controls and monitors the production line and subsequent analysis of the results using information in a quality control (QC) database to validate the results. A repository comprising the QC database and a research database receives and aggregates the results without identifying the source of the sample. A portal may be provided to provide access to the research database to a plurality of external contributors. Contributors can selectively provide additional research data and data can be processed using data mining and curation tools.
    Type: Application
    Filed: October 14, 2013
    Publication date: June 12, 2014
    Applicant: Invitae Corporation
    Inventor: Sean E. GEORGE
  • Patent number: 8600683
    Abstract: Systems and methods for biological sample processing are described. A production line extracts genomic DNA from a biological sample, amplifies target components of the sample and produces sequence data for markers from the amplified components. The markers are associated with tests identified in a requisition received with the sample and some markers may be associated with unrequisitioned tests. A sample information management system (SIMS) controls and monitors the production line and subsequent analysis of the results using information in a quality control (QC) database to validate the results. A repository comprising the QC database and a research database receives and aggregates the results without identifying the source of the sample. A portal may be provided to provide access to the research database to a plurality of external contributors. Contributors can selectively provide additional research data and data can be processed using data mining and curation tools.
    Type: Grant
    Filed: January 11, 2012
    Date of Patent: December 3, 2013
    Assignee: Invitae Corporation
    Inventor: Sean E. George